rs200644058

Variant summary

Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP4_StrongBP6

The NM_173551.5(ANKS6):​c.2564T>C​(p.Phe855Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00106 in 1,613,736 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00078 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0011 ( 1 hom. )

Consequence

ANKS6
NM_173551.5 missense

Scores

5
9
5

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:2

Conservation

PhyloP100: 8.65

Publications

4 publications found
Variant links:
Genes affected
ANKS6 (HGNC:26724): (ankyrin repeat and sterile alpha motif domain containing 6) This gene encodes a protein containing multiple ankyrin repeats and a SAM domain. It is thought that this protein may localize to the proximal region of the primary cilium, and may play a role in renal and cardiovascular development. Mutations in this gene have been shown to cause a form of nephronophthisis (NPHP16), a chronic tubulo-interstitial nephritis. [provided by RefSeq, Jul 2015]
ANKS6 Gene-Disease associations (from GenCC):
  • nephronophthisis 16
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae)
  • nephronophthisis 1
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • nephronophthisis 2
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -5 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.033640146).
BP6
Variant 9-98736571-A-G is Benign according to our data. Variant chr9-98736571-A-G is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 474451.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ANKS6NM_173551.5 linkc.2564T>C p.Phe855Ser missense_variant Exon 15 of 15 ENST00000353234.5 NP_775822.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ANKS6ENST00000353234.5 linkc.2564T>C p.Phe855Ser missense_variant Exon 15 of 15 1 NM_173551.5 ENSP00000297837.6
ANKS6ENST00000375019.6 linkc.1661T>C p.Phe554Ser missense_variant Exon 14 of 15 5 ENSP00000364159.2
ANKS6ENST00000444472.5 linkc.971T>C p.Phe324Ser missense_variant Exon 8 of 9 2 ENSP00000398648.1
ANKS6ENST00000634393.1 linkn.1699T>C non_coding_transcript_exon_variant Exon 14 of 15 5

Frequencies

GnomAD3 genomes
AF:
0.000776
AC:
118
AN:
152140
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000145
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000283
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00157
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.00111
AC:
274
AN:
247358
AF XY:
0.00104
show subpopulations
Gnomad AFR exome
AF:
0.0000651
Gnomad AMR exome
AF:
0.000116
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00103
Gnomad NFE exome
AF:
0.00215
Gnomad OTH exome
AF:
0.000993
GnomAD4 exome
AF:
0.00109
AC:
1598
AN:
1461480
Hom.:
1
Cov.:
32
AF XY:
0.00106
AC XY:
770
AN XY:
726986
show subpopulations
African (AFR)
AF:
0.0000896
AC:
3
AN:
33472
American (AMR)
AF:
0.000179
AC:
8
AN:
44692
Ashkenazi Jewish (ASJ)
AF:
0.0000383
AC:
1
AN:
26128
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39692
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86112
European-Finnish (FIN)
AF:
0.000936
AC:
50
AN:
53398
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5766
European-Non Finnish (NFE)
AF:
0.00132
AC:
1473
AN:
1111850
Other (OTH)
AF:
0.00104
AC:
63
AN:
60370
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
89
177
266
354
443
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
44
88
132
176
220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000775
AC:
118
AN:
152256
Hom.:
0
Cov.:
32
AF XY:
0.000712
AC XY:
53
AN XY:
74442
show subpopulations
African (AFR)
AF:
0.000144
AC:
6
AN:
41558
American (AMR)
AF:
0.000131
AC:
2
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4820
European-Finnish (FIN)
AF:
0.000283
AC:
3
AN:
10606
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00157
AC:
107
AN:
68010
Other (OTH)
AF:
0.00
AC:
0
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
7
14
21
28
35
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00133
Hom.:
0
Bravo
AF:
0.000620
TwinsUK
AF:
0.00135
AC:
5
ALSPAC
AF:
0.00104
AC:
4
ESP6500AA
AF:
0.000257
AC:
1
ESP6500EA
AF:
0.00121
AC:
10
ExAC
AF:
0.00170
AC:
206
EpiCase
AF:
0.00104
EpiControl
AF:
0.000772

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:2
Oct 08, 2024
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Reported in the heterozygous state in a patient with cystic kidney disease in published literature; this patient was also heterozygous for variants in other genes that may explain the phenotype (PMID: 25646624); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 25646624) -

Apr 01, 2022
CeGaT Center for Human Genetics Tuebingen
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nephronophthisis 16 Benign:1
Jan 15, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

ANKS6-related disorder Benign:1
Dec 03, 2023
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.97
BayesDel_addAF
Uncertain
0.016
T
BayesDel_noAF
Pathogenic
0.24
CADD
Pathogenic
28
DANN
Uncertain
1.0
DEOGEN2
Benign
0.082
.;T
Eigen
Uncertain
0.65
Eigen_PC
Pathogenic
0.68
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Uncertain
0.91
D;D
M_CAP
Uncertain
0.12
D
MetaRNN
Benign
0.034
T;T
MetaSVM
Uncertain
-0.091
T
MutationAssessor
Benign
0.90
.;L
PhyloP100
8.7
PrimateAI
Uncertain
0.72
T
PROVEAN
Uncertain
-4.1
D;D
REVEL
Uncertain
0.43
Sift
Pathogenic
0.0
D;D
Sift4G
Benign
0.43
T;T
Polyphen
1.0
.;D
Vest4
0.70
MVP
0.83
MPC
0.69
ClinPred
0.099
T
GERP RS
5.3
Varity_R
0.65
gMVP
0.56
Mutation Taster
=57/43
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs200644058; hg19: chr9-101498853; COSMIC: COSV99055769; API